Ireland - English - HPRA (Health Products Regulatory Authority)

techno-pharm limited - propofol - emulsion for inj/inf - 10 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - propofol 10 mg/ml;  ;  ; propofol 10 mg/ml - emulsion for injection - 10 mg/ml - active: propofol 10 mg/ml     excipient: egg lecithin glycerol sodium hydroxide sodium oleate soya oil water for injection active: propofol 10 mg/ml excipient: egg lecithin glycerol medium-chain triglycerides sodium hydroxide sodium oleate soya oil water for injection

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - propofol - emulsion for injection or infusion - propofol 20 mg/ml - propofol - propofol - propofol-lipuro 2% is a short-acting intravenous general anaesthetic for● induction and maintenance of general anaesthesia in adults and children > 3 years● sedation of ventilated patients >16 years of age in the intensive care unit● sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - propofol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - propofol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - propofol -

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; oleic acid; soya oil; sodium hydroxide; egg lecithin; water for injections - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium hydroxide; oleic acid; glycerol - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; glycerol; oleic acid; sodium hydroxide; water for injections; egg lecithin - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: sodium hydroxide; soya oil; disodium edetate; glycerol; water for injections; egg lecithin - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.